Login to Your Account



Lectus’ First Round Worth £8.2M For Lead Up To Clinic

By Nuala Moran


Wednesday, February 15, 2006
LONDON - Lectus Therapeutics Ltd. raised £8.2 million (US$14.3 million) in a first round funding that the company claims is the largest seen in Europe since 2004. The money will support development of the company’s second-generation ion channel modulators, enabling it to take the lead product into the clinic within the next three years. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription